Drug Search Results
Using advanced filters...
Advanced Search [+]

APN-201

Alternative Names: apn-201, apn201, apn 201
Clinical Status: Inactive
Latest Update: 2013-07-15
Latest Update Note: Clinical Trial Update

Product Description

a liposomal formulation of human recombinant superoxide dismutase

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Coagulation Factor

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Apeiron Biologics
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 2: Radiodermatitis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

APN201-1-01

P2

Completed

Radiodermatitis

2012-05-01

2019-03-19

Treatments

Recent News Events

Date

Type

Title